FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2313025188> ?p ?o ?g. }

• W2313025188 endingPage "1405" @default.
• W2313025188 startingPage "1395" @default.
• W2313025188 abstract "PIANO (NCT00665847) investigated etravirine pharmacokinetics, efficacy, and safety in children and adolescents. Treatment-experienced, HIV-1-infected patients (≥6 to <18 years) received etravirine 5.2 mg/kg twice daily (maximum 200 mg twice daily) plus background antiretrovirals. A population pharmacokinetic model was developed, and etravirine C0h and AUC0-12h were estimated. Relationships among intrinsic/extrinsic factors and etravirine pharmacokinetics and pharmacokinetics with pharmacodynamics were assessed. The best model describing etravirine pharmacokinetics consisted of a single compartment with sequential zero- and first-order absorption following a lag time. Interindividual variability terms were included on clearance (CL/F) and the first-order input rate constant (KA). The final model estimates (coefficient of variation, %) for CL/F and KA were 46.3 (11) L/h and 1.07 (34) h-1 , respectively. Overall, median (range) estimated etravirine C0h and AUC0-12h were 287 (2-2276) ng/mL and 4560 (62-28,865) ng · h/mL, respectively. Exposure was slightly lower in adolescents vs children. Sex and adherence did not affect etravirine pharmacokinetics. Factors significantly affecting etravirine exposure were body weight (higher with lower weight), race (lower in Asians than in white or black patients), and the use of certain HIV protease inhibitors. Virologic response (<50 copies/mL at week 48) was lower in the lowest etravirine AUC0-12h quartile vs the upper 3 quartiles (41% vs 67% to 76%). Rash occurred more frequently in the highest quartile than in the lower 3 quartiles (52% versus 8% to 20%). Etravirine 5.2 mg/kg twice daily in treatment-experienced, HIV-1-infected children and adolescents provides comparable exposure to that in adults receiving etravirine 200 mg twice daily and is the recommended dose for children and adolescents." @default.
• W2313025188 created "2016-06-24" @default.
• W2313025188 creator A5004972351 @default.
• W2313025188 creator A5030426323 @default.
• W2313025188 creator A5030862803 @default.
• W2313025188 creator A5048980547 @default.
• W2313025188 creator A5062666946 @default.
• W2313025188 creator A5081908884 @default.
• W2313025188 creator A5086420860 @default.
• W2313025188 creator A5088020835 @default.
• W2313025188 date "2016-10-06" @default.
• W2313025188 modified "2023-10-09" @default.
• W2313025188 title "Pharmacokinetics and Pharmacokinetic/Pharmacodynamic Relationships of Etravirine in HIV-1-Infected, Treatment-Experienced Children and Adolescents in PIANO" @default.
• W2313025188 cites W1483464410 @default.
• W2313025188 cites W179970603 @default.
• W2313025188 cites W1977680419 @default.
• W2313025188 cites W1984117544 @default.
• W2313025188 cites W1999580368 @default.
• W2313025188 cites W2004424444 @default.
• W2313025188 cites W2026293162 @default.
• W2313025188 cites W2034273907 @default.
• W2313025188 cites W2043317290 @default.
• W2313025188 cites W2045722802 @default.
• W2313025188 cites W2046246036 @default.
• W2313025188 cites W2051272543 @default.
• W2313025188 cites W2053570554 @default.
• W2313025188 cites W2061577259 @default.
• W2313025188 cites W2066996342 @default.
• W2313025188 cites W2074411784 @default.
• W2313025188 cites W2108962146 @default.
• W2313025188 cites W2118221302 @default.
• W2313025188 cites W2128877207 @default.
• W2313025188 cites W2140045054 @default.
• W2313025188 cites W2146577595 @default.
• W2313025188 cites W2164399329 @default.
• W2313025188 cites W2170341168 @default.
• W2313025188 cites W2172130850 @default.
• W2313025188 cites W2473415541 @default.
• W2313025188 cites W87480598 @default.
• W2313025188 doi "https://doi.org/10.1002/jcph.746" @default.
• W2313025188 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27060341" @default.
• W2313025188 hasPublicationYear "2016" @default.
• W2313025188 type Work @default.
• W2313025188 sameAs 2313025188 @default.
• W2313025188 citedByCount "4" @default.
• W2313025188 countsByYear W23130251882016 @default.
• W2313025188 countsByYear W23130251882019 @default.
• W2313025188 countsByYear W23130251882020 @default.
• W2313025188 countsByYear W23130251882021 @default.
• W2313025188 crossrefType "journal-article" @default.
• W2313025188 hasAuthorship W2313025188A5004972351 @default.
• W2313025188 hasAuthorship W2313025188A5030426323 @default.
• W2313025188 hasAuthorship W2313025188A5030862803 @default.
• W2313025188 hasAuthorship W2313025188A5048980547 @default.
• W2313025188 hasAuthorship W2313025188A5062666946 @default.
• W2313025188 hasAuthorship W2313025188A5081908884 @default.
• W2313025188 hasAuthorship W2313025188A5086420860 @default.
• W2313025188 hasAuthorship W2313025188A5088020835 @default.
• W2313025188 hasConcept C111113717 @default.
• W2313025188 hasConcept C112705442 @default.
• W2313025188 hasConcept C126322002 @default.
• W2313025188 hasConcept C142462285 @default.
• W2313025188 hasConcept C159047783 @default.
• W2313025188 hasConcept C181199279 @default.
• W2313025188 hasConcept C185592680 @default.
• W2313025188 hasConcept C2776714187 @default.
• W2313025188 hasConcept C2777351918 @default.
• W2313025188 hasConcept C2777363262 @default.
• W2313025188 hasConcept C2777583353 @default.
• W2313025188 hasConcept C2780345285 @default.
• W2313025188 hasConcept C2993143319 @default.
• W2313025188 hasConcept C3013748606 @default.
• W2313025188 hasConcept C44249647 @default.
• W2313025188 hasConcept C55493867 @default.
• W2313025188 hasConcept C68443243 @default.
• W2313025188 hasConcept C71924100 @default.
• W2313025188 hasConcept C98274493 @default.
• W2313025188 hasConceptScore W2313025188C111113717 @default.
• W2313025188 hasConceptScore W2313025188C112705442 @default.
• W2313025188 hasConceptScore W2313025188C126322002 @default.
• W2313025188 hasConceptScore W2313025188C142462285 @default.
• W2313025188 hasConceptScore W2313025188C159047783 @default.
• W2313025188 hasConceptScore W2313025188C181199279 @default.
• W2313025188 hasConceptScore W2313025188C185592680 @default.
• W2313025188 hasConceptScore W2313025188C2776714187 @default.
• W2313025188 hasConceptScore W2313025188C2777351918 @default.
• W2313025188 hasConceptScore W2313025188C2777363262 @default.
• W2313025188 hasConceptScore W2313025188C2777583353 @default.
• W2313025188 hasConceptScore W2313025188C2780345285 @default.
• W2313025188 hasConceptScore W2313025188C2993143319 @default.
• W2313025188 hasConceptScore W2313025188C3013748606 @default.
• W2313025188 hasConceptScore W2313025188C44249647 @default.
• W2313025188 hasConceptScore W2313025188C55493867 @default.
• W2313025188 hasConceptScore W2313025188C68443243 @default.
• W2313025188 hasConceptScore W2313025188C71924100 @default.
• W2313025188 hasConceptScore W2313025188C98274493 @default.
• W2313025188 hasIssue "11" @default.
• W2313025188 hasLocation W23130251881 @default.

• next